Thomas Story & Son’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.07M | Hold |
2,655
| – | – | 1.06% | 26 |
|
|
2026
Q2 | $3.18M | Hold |
2,655
| – | – | 1.13% | 26 |
|
|
2026
Q1 | $2.44M | Hold |
2,655
| – | – | 0.94% | 26 |
|
|
2025
Q4 | $2.85M | Hold |
2,655
| – | – | 1.06% | 28 |
|
|
2025
Q3 | $2.03M | Hold |
2,655
| – | – | 0.74% | 28 |
|
|
2025
Q2 | $2.07M | Hold |
2,655
| – | – | 0.8% | 29 |
|
|
2025
Q1 | $2.19M | Hold |
2,655
| – | – | 0.85% | 28 |
|
|
2024
Q4 | $2.05M | Hold |
2,655
| – | – | 0.86% | 27 |
|
|
2024
Q3 | $2.35M | Hold |
2,655
| – | – | 0.96% | 28 |
|
|
2024
Q2 | $2.4M | Hold |
2,655
| – | – | 1.04% | 28 |
|
|
2024
Q1 | $2.06M | Sell |
2,655
-75
| -3% | -$53.4K | 0.87% | 29 |
|
|
2023
Q4 | $1.59M | Hold |
2,730
| – | – | 0.75% | 29 |
|
|
2023
Q3 | $1.47M | Hold |
2,730
| – | – | 0.71% | 33 |
|
|
2023
Q2 | $1.28M | Hold |
2,730
| – | – | 0.58% | 37 |
|
|
2023
Q1 | $938K | Hold |
2,730
| – | – | 0.45% | 36 |
|
|
2022
Q4 | $999K | Hold |
2,730
| – | – | 0.51% | 35 |
|
|
2022
Q3 | $883K | Hold |
2,730
| – | – | 0.46% | 36 |
|
|
2022
Q2 | $885K | Hold |
2,730
| – | – | 0.42% | 37 |
|
|
2022
Q1 | $782K | Hold |
2,730
| – | – | 0.31% | 41 |
|
|
2021
Q4 | $754K | Hold |
2,730
| – | – | 0.29% | 40 |
|
|
2021
Q3 | $631K | Hold |
2,730
| – | – | 0.26% | 45 |
|
|
2021
Q2 | $627K | Hold |
2,730
| – | – | 0.23% | 45 |
|
|
2021
Q1 | $510K | Buy |
2,730
+30
| +1% | +$5.87K | 0.19% | 47 |
|
|
2020
Q4 | $456K | Hold |
2,700
| – | – | 0.19% | 46 |
|
|
2020
Q3 | $400K | Hold |
2,700
| – | – | 0.18% | 45 |
|
|
2020
Q2 | $443K | Hold |
2,700
| – | – | 0.21% | 44 |
|
|
2020
Q1 | $375K | Hold |
2,700
| – | – | 0.22% | 44 |
|
|
2019
Q4 | $355K | Hold |
2,700
| – | – | 0.17% | 43 |
|
|
2019
Q3 | $302K | Hold |
2,700
| – | – | 0.16% | 46 |
|
|
2019
Q2 | $299K | Hold |
2,700
| – | – | 0.15% | 44 |
|
|
2019
Q1 | $350K | Hold |
2,700
| – | – | 0.18% | 42 |
|
|
2018
Q4 | $312K | Hold |
2,700
| – | – | 0.19% | 44 |
|
|
2018
Q3 | $290K | Hold |
2,700
| – | – | 0.15% | 47 |
|
|
2018
Q2 | $230K | Hold |
2,700
| – | – | 0.13% | 51 |
|
|
2018
Q1 | $209K | Hold |
2,700
| – | – | 0.12% | 55 |
|
|
2017
Q4 | $228K | Hold |
2,700
| – | – | 0.13% | 52 |
|
|
2017
Q3 | $231K | Hold |
2,700
| – | – | 0.12% | 50 |
|
|
2017
Q2 | $222K | Hold |
2,700
| – | – | 0.13% | 51 |
|
|
2017
Q1 | $227K | Buy |
+2,700
| New | +$216K | 0.13% | 50 |
|
|
2016
Q4 | – | Sell |
-2,700
| Closed | -$217K | – | 49 |
|
|
2016
Q3 | $217K | Hold |
2,700
| – | – | 0.13% | 46 |
|
|
2016
Q2 | $213K | Buy |
+2,700
| New | +$203K | 0.13% | 46 |
|
|
2016
Q1 | – | Sell |
-2,700
| Closed | -$228K | – | 49 |
|
|
2015
Q4 | $228K | Hold |
2,700
| – | – | 0.14% | 45 |
|
|
2015
Q3 | $226K | Hold |
2,700
| – | – | 0.15% | 49 |
|
|
2015
Q2 | $225K | Buy |
+2,700
| New | +$206K | 0.14% | 50 |
|
Other funds holding LLY
Thomas Story & Son's LLY Position: Q3 2026 in Review
Thomas Story & Son held its Eli Lilly (LLY) position steady in Q3 2026 at 2,655 shares worth $3.07M. The position accounts for 1.06% of the portfolio, ranked #26.
Thomas Story & Son first reported a position in LLY in Q2 2015 and has held it in 44 quarters since. The position peaked at $3.18M in Q2 2026. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Thomas Story & Son held 2,655 shares of Eli Lilly worth $3.07M as of Q3 2026.
- Thomas Story & Son left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 1.06% of Thomas Story & Son's portfolio in Q3 2026, its #26 holding.
- Thomas Story & Son first reported a position in Eli Lilly in Q2 2015 and has held it in 44 quarters since.
- Thomas Story & Son's Eli Lilly position peaked at $3.18M in Q2 2026.
- 1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Thomas Story & Son's 13F filing for Q3 2026, filed 13 Oct 2026.